Yuting Sang

2.2k total citations · 1 hit paper
20 papers, 1.5k citations indexed

About

Yuting Sang is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Yuting Sang has authored 20 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 13 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Yuting Sang's work include Circular RNAs in diseases (11 papers), MicroRNA in disease regulation (8 papers) and Breast Cancer Treatment Studies (5 papers). Yuting Sang is often cited by papers focused on Circular RNAs in diseases (11 papers), MicroRNA in disease regulation (8 papers) and Breast Cancer Treatment Studies (5 papers). Yuting Sang collaborates with scholars based in China, Canada and United States. Yuting Sang's co-authors include Qifeng Yang, Yiran Liang, Hanwen Zhang, Ying Liu, Yaming Li, Ning Zhang, Xiaojin Song, Wenjing Zhao, Bing Chen and Lijuan Wang and has published in prestigious journals such as Cancer Research, Oncogene and International Journal of Molecular Sciences.

In The Last Decade

Yuting Sang

20 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer

2019 340 citations Yuting Sang, Bing Chen et al. Molecular Therapy profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yuting Sang China	12	1.2k	1.2k	133	85	77	20	1.5k
Liwei Qiu China	18	427 0.4×	294 0.3×	165 1.2×	112 1.3×	40 0.5×	51	877
Xuenong Li China	21	1.1k 0.9×	912 0.8×	207 1.6×	139 1.6×	141 1.8×	47	1.4k
Wenjun Cheng China	18	650 0.5×	457 0.4×	122 0.9×	150 1.8×	75 1.0×	56	963
Yan Zeng China	19	1.6k 1.3×	1.1k 1.0×	346 2.6×	210 2.5×	107 1.4×	50	1.9k
Changqing Jing China	14	484 0.4×	378 0.3×	136 1.0×	128 1.5×	55 0.7×	56	794
Giovanni Calice Italy	14	291 0.2×	172 0.1×	117 0.9×	79 0.9×	48 0.6×	39	549
Weijie Liao China	13	684 0.6×	479 0.4×	122 0.9×	99 1.2×	121 1.6×	41	1.1k
Yongfu Ma China	18	550 0.5×	475 0.4×	150 1.1×	193 2.3×	86 1.1×	44	945
Ting Zhan China	15	311 0.3×	295 0.3×	194 1.5×	73 0.9×	36 0.5×	32	610
Fuyin Zhang China	12	345 0.3×	188 0.2×	164 1.2×	55 0.6×	95 1.2×	27	622

Countries citing papers authored by Yuting Sang

Since Specialization

Citations

This map shows the geographic impact of Yuting Sang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuting Sang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuting Sang more than expected).

Fields of papers citing papers by Yuting Sang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuting Sang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuting Sang. The network helps show where Yuting Sang may publish in the future.

Co-authorship network of co-authors of Yuting Sang

This figure shows the co-authorship network connecting the top 25 collaborators of Yuting Sang. A scholar is included among the top collaborators of Yuting Sang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuting Sang. Yuting Sang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chi, Weiru, Bingqiu Xiu, Pei Li, et al.. (2023). MNX1 Promotes Anti-HER2 Therapy Sensitivity via Transcriptional Regulation of CD-M6PR in HER2-Positive Breast Cancer. International Journal of Molecular Sciences. 25(1). 221–221. 2 indexed citations

Li, Lulu, Nan Yang, Taoyun Ji, et al.. (2023). Identification of gene mutations in six Chinese patients with maple syrup urine disease. Frontiers in Genetics. 14. 1132364–1132364. 5 indexed citations

Sang, Yuting, Jiajian Chen, Benlong Yang, et al.. (2023). Abstract P2-14-02: Surgical options of the breast and clinical outcomes in breast cancer patients after neoadjuvant chemotherapy: a single-center retrospective study. Cancer Research. 83(5_Supplement). P2–14. 1 indexed citations

Sang, Yuting, Benlong Yang, Miao Mo, et al.. (2022). Treatment and survival outcomes in older women with primary breast cancer: A retrospective propensity score-matched analysis. The Breast. 66. 24–30. 4 indexed citations

Sang, Yuting, Weiru Chi, Jiajian Chen, et al.. (2022). Surgical options of the breast and clinical outcomes of breast cancer patients after neoadjuvant chemotherapy: A single-center retrospective study. Frontiers in Oncology. 12. 984587–984587. 6 indexed citations

Zhou, Shu‐Feng, Yuting Sang, Jiajian Chen, et al.. (2022). Comparison of Time-Varying Pattern of Recurrence in Chinese Breast Cancer Patients with Different Molecular Subtypes: A Single-Center Retrospective Study. ONCOLOGIE. 24(3). 451–469. 2 indexed citations

Su, Yonghui, Yuchen Li, Rong Guo, et al.. (2021). Plasma extracellular vesicle long RNA profiles in the diagnosis and prediction of treatment response for breast cancer. npj Breast Cancer. 7(1). 154–154. 31 indexed citations

Chen, Bing, Yuting Sang, Xiaojin Song, et al.. (2021). Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28. Theranostics. 11(8). 3932–3947. 178 indexed citations

Liang, Yiran, Xiaojin Song, Yaming Li, et al.. (2021). Correction: circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer. Oncogene. 40(15). 2816–2816. 2 indexed citations

10.

Zhao, Xuehua, et al.. (2021). Enhancing robustness of monthly streamflow forecasting model using gated recurrent unit based on improved grey wolf optimizer. Journal of Hydrology. 601. 126607–126607. 62 indexed citations

11.

Song, Xiaojin, Yiran Liang, Yuting Sang, et al.. (2020). circHMCU Promotes Proliferation and Metastasis of Breast Cancer by Sponging the let-7 Family. Molecular Therapy — Nucleic Acids. 20. 518–533. 48 indexed citations

12.

Zhang, Hanwen, Ning Zhang, Ying Liu, et al.. (2019). Epigenetic Regulation of NAMPT by NAMPT-AS Drives Metastatic Progression in Triple-Negative Breast Cancer. Cancer Research. 79(13). 3347–3359. 107 indexed citations

13.

Sang, Yuting, Bing Chen, Xiaojin Song, et al.. (2019). circRNA_0025202 Regulates Tamoxifen Sensitivity and Tumor Progression via Regulating the miR-182-5p/FOXO3a Axis in Breast Cancer. Molecular Therapy. 27(9). 1638–1652. 340 indexed citations breakdown →

14.

Liang, Yiran, Xiaojin Song, Yaming Li, et al.. (2019). Targeting the circBMPR2/miR-553/USP4 Axis as a Potent Therapeutic Approach for Breast Cancer. Molecular Therapy — Nucleic Acids. 17. 347–361. 65 indexed citations

15.

Sang, Yuting, Xiaoli Kong, Xiaoyan Li, et al.. (2019). Langer's axillary arch lymph node metastasis in breast cancer patients: A prospective clinical study. Surgical Oncology. 29. 48–52. 5 indexed citations

16.

Liang, Yiran, Xiaojin Song, Yaming Li, et al.. (2019). circKDM4C suppresses tumor progression and attenuates doxorubicin resistance by regulating miR-548p/PBLD axis in breast cancer. Oncogene. 38(42). 6850–6866. 113 indexed citations

17.

Kong, Xiaoli, Yi Duan, Yuting Sang, et al.. (2018). LncRNA–CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA‐215. Journal of Cellular Physiology. 234(6). 9105–9117. 233 indexed citations

18.

Liang, Yiran, Xiaojin Song, Yaming Li, et al.. (2018). A novel long non-coding RNA-PRLB acts as a tumor promoter through regulating miR-4766-5p/SIRT1 axis in breast cancer. Cell Death and Disease. 9(5). 563–563. 59 indexed citations

19.

Li, Yaming, Yiran Liang, Yuting Sang, et al.. (2018). MiR-770 suppresses the chemo-resistance and metastasis of triple negative breast cancer via direct targeting of STMN1. Cell Death and Disease. 9(1). 14–14. 145 indexed citations

20.

Liang, Yiran, Yaming Li, Xiaojin Song, et al.. (2018). Long noncoding RNA LINP1 acts as an oncogene and promotes chemoresistance in breast cancer. Cancer Biology & Therapy. 19(2). 120–131. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact